“…Similarly to other authors and based on clinical effectiveness, cost-effectiveness, safety, equity, and ethics, we believe that there is no current justification for preventing this group from taking advantage of this life-changing treatment. Ultimately, a day-case LSG booming in ambulatory surgery centers should be anticipated for these patients [24].…”